Tradestie Institutional Equity Comparison Engine · Market Close Nov 16, 2026

IXC vs IXJ: Which Stock Is the Better Buy Now?

Deterministic 6-pillar institutional evaluation across valuation multiples, TTM & multi-year operating margins, cash generation, options IV skew, and supply-chain moat.

IXJ Wins Head-to-Head Institutional Verdict (0–0 across 6 Pillars · 2–1 Matrix Metrics)

IXJ Overall Winner 6-Pillar Tally: IXC 0 – 0 IXJ (6 Tie) Matrix Metrics: IXC 1 – 2 IXJ

As of Nov 16, 2026, iShares Global Healthcare ETF (IXJ) is the stronger overall head-to-head candidate over iShares Global Energy ETF (IXC) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IXC carries a Unified Composite Score of 53.5/100 (HOLD) at $58.21 (N/M Forward P/E, N/A operating margin), whereas IXJ carries 35.4/100 (SELL) at $114.23 (N/M Forward P/E, N/A operating margin).

  • Composite vs. Pillar Nuance: While IXC currently prints a higher short-term Unified Composite Score (53.5/100 HOLD vs. IXJ 35.4/100 SELL), IXJ captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

Executive Snapshot Side-by-Side Composite Ratings & Technical Regime

Ask Alpha AI About IXC vs IXJ
IXC NYSE Arca
iShares Global Energy ETF
Institutional Equity
$58.21
-1.9% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol -0.42β · 27% Vol
Unified Composite Score
53.5 / 100 HOLD
Tech 57.0 Fund 49.0 Flow 50.0 Mom 36.0
Weinstein Technical Phase Neutral · Hold
Mixed signals - no dominant trend phase, RSI 42
RSI-14: 42.5 · SMA20: $60.65 · SMA50: $59.80
IXJ NYSE Arca Head-to-Head Winner
iShares Global Healthcare ETF
Institutional Equity
$114.23
-0.44% 1D
Market Cap N/A
TTM Revenue N/A
Forward P/E N/M
Beta / 30D Vol 0.30β · 20% Vol
Unified Composite Score
35.4 / 100 SELL
Tech 26.0 Fund 33.0 Flow 50.0 Mom 21.1
Weinstein Technical Phase Markup · Hold / add on dips
Price above SMA50, rising 50-day trend (2.8% over 20 days), RSI 66
RSI-14: 65.9 · SMA20: $112.21 · SMA50: $106.64

6-Pillar Scorecard Institutional Category Breakdown (IXC 0 – 0 IXJ)

Columns: Metric · IXC · IXJ
1. Valuation Multiples Tie
Forward P/E N/M N/M
Trailing P/E N/M N/M
PEG Ratio N/M N/M
EV / Revenue N/M N/M
2. Growth & Scale Tie
Revenue Growth (YoY) N/A N/A
Earnings Growth (YoY) N/A N/A
TTM Revenue (USD) N/A N/A
Market Cap N/A N/A
3. Profitability & Quality Tie
Gross Margin N/A N/A
Operating Margin N/A N/A
Net Profit Margin N/A N/A
Return on Equity (ROE) N/A N/A
4. Balance Sheet & Cash Flow Tie
Cash Generation (TTM) N/A N/A
Cash Flow Margin N/A N/A
Net Cash / Leverage N/A ROE N/A ROE
Dividend Yield None (0.00%) None (0.00%)
5. Options & Positioning Tie
Options Structure Phase UNCLASSIFIED UNCLASSIFIED
Current IV / %ile 18.2% (6th %ile) 12.4% (1st %ile)
Put/Call OI Skew N/A N/A
OBV Trend / Tech Phase NEUTRAL · Neutral NEUTRAL · Markup
6. R&D & Supply-Chain Moat Tie
OpEx & R&D Intensity N/A N/A
90D R&D Disclosures 0 papers 0 papers
Competitive Moat Cyclical / Execution-Driven Positioning Cyclical / Execution-Driven Positioning
Supply-Chain Role Institutional Equity Operator Institutional Equity Operator

Core Matrix Head-to-Head Valuation, Margin, Cash Flow & Risk Table

Core Matrix Wins: IXC (1) vs IXJ (2)
Institutional Metric IXC IXJ Criterion Row Edge
Market Capitalization
Scale
N/A N/A Larger Scale Tie
Trailing P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Forward P/E Ratio
Valuation
N/M N/M Lower Multiple Tie
Revenue Growth (YoY)
Growth
N/A N/A Higher Growth Tie
Operating Margin (TTM)
Profitability
N/A N/A Higher Margin Tie
Net Profit Margin
Profitability
N/A N/A Higher Margin Tie
Return on Equity (ROE)
Capital Efficiency
N/A N/A Higher ROE Tie
52-Week Range Position
Momentum
74% ($41–$64) 90% ($90–$117) Stronger Trend IXJ
Beta / 30D Volatility
Risk Regime
-0.42β · 27% Vol 0.30β · 20% Vol Lower Realized Risk IXJ
Unified Institutional Score
Composite Signal
53.5 / 100 (HOLD) 35.4 / 100 (SELL) Higher Composite IXC
Trailing 12M Revenue (USD)
Operating Scale
N/A N/A FX-Normalized USD Scale
Gross Profit Margin (TTM)
Unit Pricing Power
N/A N/A Higher Margin Quality
PEG Ratio & EV / Revenue
Growth-Adjusted Valuation
N/M PEG · N/M EV/Rev N/M PEG · N/M EV/Rev Lower Multiple Valuation
Cash Flow & Balance Sheet
Capital Self-Funding
N/A (N/A ROE) N/A (N/A ROE) Higher Cash / Net Cash Solvency

Momentum Normalized Relative Price Performance (1M · 3M · 6M · 1Y)

1M Horizon IXJ +14.4 pp
IXC: -7.57% · IXJ: +6.83%
3M Horizon IXJ +9.78 pp
IXC: +0.15% · IXJ: +9.93%
6M Horizon IXJ +21.8 pp
IXC: +1.77% · IXJ: +23.57%
1Y Horizon IXC +16.77 pp
IXC: +35.5% · IXJ: +18.73%

Financial Trajectory Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant USD Revenue & Operating Margin (%)

Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on IXC vs IXJ. Trailing 12-month operating profitability (IXC N/A vs IXJ N/A) and valuation multiples (IXC N/M vs IXJ N/M Forward P/E) are benchmarked directly in Pillar 4 below.

IXC ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M
IXJ ADR TTM Benchmark FX-Normalized USD
TTM RevenueN/A
Gross MarginN/A
Op. MarginN/A
ROE / Fwd P/EN/A · N/M

Options Positioning Implied Volatility, Put/Call Skew & Dealer Gamma Corridor

Live Options Phase Tracker
IXC UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 18.2%
IV Percentile 6th %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IXC Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →
IXJ UNCLASSIFIED
0d in phase · OBV NEUTRAL
Current IV 12.4%
IV Percentile 1st %ile
Put/Call OI Skew N/A
IV Regime Compressed (<25th %ile)
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
Net Delta Signal NEUTRAL
OBV Flow NEUTRAL
Exact IXJ Put/Call Gamma Wall strikes & dealer pinning corridor require Tradestie Pro. Unlock 14-Day Free Trial →

Moat & R&D Supply-Chain Positioning, Bottleneck Moat & R&D Velocity

Corporate R&D & Foundry Leaderboard
IXC Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published
IXJ Moat Profile Cyclical / Execution-Driven Positioning
Institutional Equity Operator
Competes within the Institutional Equity value chain with N/A market capitalization and N/A operating margin.
OpEx & R&D Reinvestment N/A
90D Engineering Disclosures 0 Published

Investor FAQ IXC vs IXJ Key Questions & Quantitative Answers

As of Nov 16, 2026, iShares Global Healthcare ETF (IXJ) is the stronger overall head-to-head candidate over iShares Global Energy ETF (IXC) in the Tradestie Institutional Equity Comparison Engine, winning 2–1 core matrix metrics and 0–0 across our 6-pillar institutional scorecard (led by composite factor balance). IXC carries a Unified Composite Score of 53.5/100 (HOLD) at $58.21 (N/M Forward P/E, N/A operating margin), whereas IXJ carries 35.4/100 (SELL) at $114.23 (N/M Forward P/E, N/A operating margin). Composite vs. Pillar Nuance: While IXC currently prints a higher short-term Unified Composite Score (53.5/100 HOLD vs. IXJ 35.4/100 SELL), IXJ captures the overall institutional head-to-head verdict (2–1 matrix metrics and 0–0 across the 6 pillars) due to superior fundamental profitability (N/A vs. N/A operating margin) and revenue trajectory (N/A vs. N/A YoY).

IXC and IXJ split Growth & Scale metrics: IXC posts N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin), compared with IXJ at N/A YoY revenue growth and N/A YoY earnings growth on N/A TTM revenue (N/A gross margin, N/A operating margin). On trailing 12-month operating scale, IXC generates N/A in USD-normalized revenue versus N/A for IXJ. In operating R&D and SG&A reinvestment, IXC deploys N/A (0 90-day corporate R&D disclosures) versus N/A (0 disclosures) for IXJ.

IXC and IXJ trade at balanced relative valuation multiples. IXC trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin), whereas IXJ trades at N/M Forward P/E, N/M Trailing P/E, N/M PEG, and N/M EV/Revenue (unreported cash flow margin). Multiples above 150x or negative earnings denominators are marked N/M to avoid distorted accounting comparisons; weigh lower Forward P/E and PEG against IXC (N/A ROE) versus IXJ (N/A ROE) capital efficiency.

In options market volatility and institutional positioning, IXC carries 18.2% implied volatility (6th %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (-0.42β · 27% Vol realized risk). By comparison, IXJ carries 12.4% implied volatility (1st %ile, Compressed (<25th %ile)), unclassified Put/Call open interest, NEUTRAL on-balance volume, and sits in an UNCLASSIFIED options structure phase (0.30β · 20% Vol realized risk).

Cross-Compare 1-Click Peer Rivalries & Single-Stock Research

Launch Custom Ticker Comparison →

Powered by Tradestie Institutional Equity Comparison Engine & standardized corporate financial telemetry. Market close as of Nov 16, 2026. For educational research only; not investment advice.